Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$3.15 - $7.94 $48,195 - $121,482
-15,300 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$6.18 - $14.44 $94,554 - $220,932
15,300 New
15,300 $95,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $70.5M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Cannon Global Investment Management, LLC Portfolio

Follow Cannon Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannon Global Investment Management, LLC with notifications on news.